MedPath

Procedural Propofol Sedation with ketamine versus alfentanil and remifentanil.

Conditions
We evaluate the role of injection of ketamine as an analgesic component of anesthesia in comparison with the other analgesics (opioids) in procedural sedation and analgesia therapy (PSA) because of the increasing importance of physician’s satisfaction during performing procedures and patient’s comfort.
Registration Number
NL-OMON29416
Lead Sponsor
Catharina Hospital EindhovenMichelangelolaan 25623 EJ EindhovenThe Netherlands040-2399111www.cze.nl
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

Inclusion criteria are requirement for PSA, patients aged 18 years or older and with an American Society of Anesthesiology class 1 to 3. Patients will be included in this study after given written informed consent before the treatment starts.

Exclusion Criteria

Patients will be excluded form the study if they are unable to give informed consent, are pregnant, has a known allergy to either study medication, are receiving treatment for neuromuscular or psychiatric disease or has a physical or communicational disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint of this study is physician’s satisfaction with the applied sedation technique, measured on a Likert five-item scoring system.
Secondary Outcome Measures
NameTimeMethod
Observer’s Assessment of Alertness/ Sedation score, Ramsay score, hemodynamic parameters (mean heart rate, mean systolic blood pressure, mean diastolic blood pressure), respiratory parameters (mean Spo2 values, mean end-tidal co2 values, mean respiratory rated and number of apneas during the procedure), times (time of induction, time required for the procedure, sedation time and recovery time), total dosage of medication needed during the procedure, pain, Aldrete score, patients’ satisfaction and side effects (nausea, vomiting).<br>
© Copyright 2025. All Rights Reserved by MedPath